FDA expanding access to pancreatic cancer drug to some patients
Summary
The FDA announced it will allow more patients to access a new drug for pancreatic cancer. This drug showed in a large study that it almost doubled the time patients with advanced pancreatic cancer survived.Key Facts
- The FDA is expanding access to a pancreatic cancer drug.
- The drug helped patients with advanced pancreatic cancer live nearly twice as long.
- The evidence comes from a large clinical trial, which tests how well a drug works.
- The expansion means more patients can get the drug earlier or more easily.
- Pancreatic cancer is a serious disease with limited treatment options.
- The FDA is responsible for approving and regulating medicines in the U.S.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.